Medical Digest & Congress Report
Episodes
Efficacy and Safety of Sotatercept in PH-HFpEF: Results From the Phase 2 CADENCE Trial - report from ACC 2026
22 Apr 2026
Contributed by Lukas
Professor Mardi Gomberg-Maitland presents the results from the Phase 2 CADENCE trial, investigating the efficacy and safety of Sotatercept in patients...
Therapeutic Novelties in the New ACC 2026 Acute Pulmonary Embolism Guideline
22 Apr 2026
Contributed by Lukas
Professor Geoffrey D. Barnes examines the therapeutic innovations introduced in the new ACC 2026 Acute Pulmonary Embolism Guideline, focusing on updat...
Human Challenge Models: A New Gold Standard? - Report from WVCDC 2026
20 Apr 2026
Contributed by Lukas
Dr. Stephen Thomas examines the evolving role of human challenge models in vaccine development, debating whether they represent a new gold standard fo...
The INSIS Metacohort Vaccine Safety Study: A Paradigm for Clinical and Immune AEFI Profiling - Report from WVCDC 2026
20 Apr 2026
Contributed by Lukas
Professor Asimenia Angelidou discusses the INSIS Metacohort Vaccine Safety Study, establishing a new paradigm for profiling clinical and immune advers...
Building a Future of Vaccine Trust Through Transparency and Innovation - Report from WVCDC 2026
17 Apr 2026
Contributed by Lukas
Dr. Yurong Fei-Bloom explores the essential strategies for fostering public confidence in immunization by prioritizing transparency and leveraging tec...
Prove it's safe: Is this the new vaccine policy "norm?" - Report from WVCDC 2026
17 Apr 2026
Contributed by Lukas
Dr. Richard Hughes IV examines the shifting landscape of immunization mandates and public health legislation, questioning whether the heightened deman...
Combining Respiratory Vaccines - Balancing Efficacy, Durability and Immunization Schedules - Report from WVCDC 2026
17 Apr 2026
Contributed by Lukas
Dr. Bill Hausdorff explores the complex dynamics of combining respiratory vaccines, focusing on how to optimize clinical efficacy and long-term durabi...
Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction - report from ACC 2026
16 Apr 2026
Contributed by Lukas
Professor Joo-Yong Hahn presents critical insights on the discontinuation of beta-blocker therapy in stabilized patients following an acute myocardial...
Meet the Experts: 2025 High Blood Pressure Guideline - report from ACC 2026
16 Apr 2026
Contributed by Lukas
Professor Daniel Jones joins a panel of distinguished specialists to provide expert commentary on the 2025 High Blood Pressure Guideline, focusing on ...
2026 Acute Pulmonary Embolism Guideline
16 Apr 2026
Contributed by Lukas
Professor Gregory Piazza provides an expert overview of the newly released 2026 Acute Pulmonary Embolism Guideline, focusing on critical updates in di...
Meet the Experts: 2025 High Blood Pressure Guideline - report from ACC 2026
16 Apr 2026
Contributed by Lukas
Professor Keith C. Ferdinand joins a panel of experts to discuss the practical implementation and clinical implications of the 2025 High Blood Pressur...
Kardinal: A Phase 2 Study of Tonlamarsen For the Treatment of Uncontrolled Hypertension - report from ACC 2026
16 Apr 2026
Contributed by Lukas
Dr. Luke Laffin presents the results of the Kardinal Phase 2 study, investigating the efficacy of Tonlamarsen as a novel treatment option for patients...
Pulmonary Embolism in 2026: A Case-Based Journey From Diagnosis to Recovery - report from ACC 2026
16 Apr 2026
Contributed by Lukas
Prof. Stanislav Henkin and Prof. Daniella Kadian-Dodov lead a comprehensive, case-based exploration of pulmonary embolism management in 2026, tracking...
Mavacamten in Symptomatic Adolescent Patients With Obstructive HCM: Results From the Phase 3 Scout-HCM Trial - report from ACC 2026
16 Apr 2026
Contributed by Lukas
Professor Joseph William Rossano presents the highly anticipated results from the Phase 3 Scout-HCM trial, evaluating the efficacy and safety of Mavac...
Saving Women's Hearts - report from ACC 2026
15 Apr 2026
Contributed by Lukas
Professor Roxana Mehran addresses the critical need for gender-specific approaches in cardiovascular care, discussing strategies and clinical advancem...
Highlights of the 2026 ACC/AHA Dyslipidemia Guideline
15 Apr 2026
Contributed by Lukas
Professor Carol F. Kirkpatrick highlights the most critical updates and clinical recommendations from the 2026 ACC/AHA Dyslipidemia Guideline, focusin...
An Update on Cardiac Prevention Medications: Hypertension and Incretin in Focus - report from ACC 2026
15 Apr 2026
Contributed by Lukas
Professor Peter P. Toth provides a comprehensive update on the latest pharmacological strategies in cardiac prevention, specifically focusing on the e...
Effects of Tirzepatide vs. Dulaglutide on Cardiorenal Outcomes: SURPASS-CVOT Analysis - report from ACC 2026
15 Apr 2026
Contributed by Lukas
Professor Steven E. Nissen presents a critical analysis of the SURPASS-CVOT data, comparing the effects of Tirzepatide and Dulaglutide on expanded car...
Next-Generation Lipid Treatment Options - report from ACC 2026
15 Apr 2026
Contributed by Lukas
Professor Robert S. Rosenson explores the evolving landscape of lipid management, detailing next-generation treatment options and their potential to t...
Fine tuning prostate cancer diagnostics - report from EAU 2026
15 Apr 2026
Contributed by Lukas
Professor Armando Stabile discusses the latest advancements and precision methods in fine tuning prostate cancer diagnostics at the EAU 2026 Annual Co...
Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI - report from ACC 2026
10 Apr 2026
Contributed by Lukas
Prof. Misa Fister and Prof. Tomaz Goslar evaluate the clinical impact and safety of prehospital heparin administration for patients with STEMI undergo...
Interventional Cardiology Highlights of ACC.26
10 Apr 2026
Contributed by Lukas
Professor Roxana Mehran provides an expert review of the most impactful interventional cardiology developments from the ACC 2026 Annual Congress, focu...
Efficacy and Safety of Enlicitide Decanoate: Results from the Phase 3 CORALreef AddOn Trial - report from ACC 2026
10 Apr 2026
Contributed by Lukas
Professor Alberico L. Catapano presents findings from the Phase 3 CORALreef AddOn trial, evaluating the oral PCSK9 inhibitor enlicitide decanoate vers...
Highlights of ACC.26
10 Apr 2026
Contributed by Lukas
Professor Christopher Kramer shares the most significant breakthroughs, late-breaking clinical trials, and key takeaways from the ACC 2026 Annual Cong...
2026 Acute Pulmonary Embolism Guideline
10 Apr 2026
Contributed by Lukas
Professor Mark A. Creager provides an in-depth overview of the newly released 2026 Acute Pulmonary Embolism Guideline, highlighting key updates in cli...
Cutting-edge strategies in bladder cancer: Trials, techniques, and predictive tools - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Richard P. Meijer explores the frontier of bladder cancer management, focusing on innovative clinical trials, advanced surgical techniques, ...
MIBC - There is a gender bias in bladder cancer diagnosis and treatment - Women experience delays, misdiagnosis, worse outcomes - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Niyati Lobo addresses the critical issue of gender bias in bladder cancer, highlighting how diagnostic delays and misdiagnoses lead to signi...
Guidelines Controversies - Paeds and MIBC - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Antoine G. van der Heijden explores the most debated topics within the EAU Guidelines, focusing on the latest controversies in pediatric uro...
Adaptive recurrence risk predictions to optimise prostate cancer follow-up: Results of model validation and clinical impact - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Joran Schoorlemmer presents the results of model validation and the clinical impact of adaptive recurrence risk predictions, focusing on how these too...
The role of urine biomarkers in detection of bladder cancer - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Yair Lotan examines the clinical utility and future potential of urine biomarkers, focusing on how they are transforming the early detection...
Urology trials in bladder and prostate cancer - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Ashkan Mortezavi provides a comprehensive overview of the most significant recent and ongoing clinical trials in bladder and prostate cancer...
Cutting-edge strategies in bladder cancer: Trials, techniques, and predictive tools - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Nikhil Vasdev explores the latest advancements in bladder cancer management, focusing on clinical trials, innovative surgical techniques, an...
Redefining EMBARK-like Patients in the PSMA Era: Impact of PSMA-PET Restaging on Disease Classification and Management - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Alessandro Viti discusses the impact of PSMA-PET restaging on disease classification and management, redefining "EMBARK-like" pati...
Progression-free survival following primary staging with [¹⁸F]PSMA-1007 PET/ceCT versus Na[¹⁸F]F-PET/ceCT in prostate cancer: Results from the PRISMA PET randomized controlled trial
07 Apr 2026
Contributed by Lukas
Karen Middelbo Buch-Olsen and Mads Hvid Poulsen present the highly anticipated results from the PRISMA PET randomized controlled trial, comparing prog...
2026 EAU Guidelines update and controversies – Urolithiasis, female and male LUTS and infections: What has changed?
07 Apr 2026
Contributed by Lukas
Professor Arjun Konath Nambiar provides a critical update on the 2026 EAU Guidelines, exploring the latest changes and ongoing controversies in urolit...
Infections: Prophylactic antibiotics in renal cancer surgery - Safeguarding patients from postoperative infection - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Florian M. E. Wagenlehner discusses the critical role of prophylactic antibiotics in renal cancer surgery and effective strategies for safeg...
Antibiotics & renal health: Striking the perfect balance between benefit and risk - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Merel M.C. Lambregts discusses the delicate clinical challenge of antibiotics and renal health, exploring how to strike the perfect balance ...
Navigating the future of urologic care - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Andreas Røder discusses the evolving landscape and strategic shifts navigating the future of urologic care at the EAU 2026 Annual Congress....
From MRI to Post-treatment care: prostate cancer screening - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Hendrik Van Poppel discusses the complete pathway of prostate cancer screening, from the initial role of MRI to the nuances of post-treatmen...
Prostate cancer: PARPIs finally explained - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Alexander W. Wyatt breaks down the complexities of PARP inhibitors (PARPIs), providing a clear and comprehensive explanation of their role i...
Retroperitoneal lymph dissection considerations in testicular cancer - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Anna Thor discusses the critical clinical considerations and surgical nuances of retroperitoneal lymph node dissection in the management of ...
How imaging is shaping prostate cancer management: Screening and early detection - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Laurence H. Klotz discusses the promising trends in screening and early detection, highlighting how imaging is shaping the future of prostat...
Advancing BPO treatment: From aquablation to enucleation - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Bogdan Florin Geavlete explores the evolution of BPO treatment, covering advancements from aquablation to enucleation techniques at the EAU ...
Kidney stones made simple: Best clinical practice and preventing complications - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Begoña Ballesta Martínez provides a comprehensive update for all urologists, focusing on best clinical practices and strategies for preven...
Kidney stones made simple: A comprehensive update for all urologists - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Mariela Corrales Acosta provides a comprehensive update on kidney stone management, simplifying complex clinical challenges for all urologis...
Navigating the future of urologic care: Trials in progress - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Tyler M. Seibert discusses the upcoming breakthroughs and ongoing clinical trials navigating the future of urologic care at the EAU 2026 Ann...
How imaging is shaping prostate cancer management - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Giovanni Lughezzani discusses the transformative role of imaging in shaping the management of prostate cancer at the EAU 2026 Annual Congres...
Increasing role of triple therapy in COPD - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Fabiano Di Marco ediscusses the increasing role of triple therapy in COPD at the 13th International Workshop On Lung Health.Video: https://m...
Redefining epithelial driven airway inflammation: insights from clinical experience with Tezepelumab - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Corrado Pelaia explains his insights from clinical experience with Tezepelumab at the 13th International Workshop On Lung Health.Video: http...
How should COPD disease characteristics guide therapeutic decisions?
30 Jan 2026
Contributed by Lukas
Professor Dejan Radovanovic discusses how should COPD disease characteristics guide therapeutic decisions at the 13th International Workshop On Lung H...
How to improve the management of newly diagnosed asthma? - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Guy Brusselle discusses how to improve the management of newly diagnosed asthma at the 13th International Workshop On Lung Health.Video: htt...
Adult Cystic Fibrosis - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Francesco Blasi explains his thoughts on the treatment of adult cystic fibrosis at the 13th International Workshop On Lung Health.Video: htt...
Clinical remission of asthma: from biologics to inhaled drugs - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Giorgio Walter Canonica explains his thoughts on the clinical remission of asthma at the 13th International Workshop On Lung Health.Video: h...
Treatment response trajectories to biologics for severe eosinophilic asthma and achievement of clinical remission - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Johann Christian Virchow discusses the treatment response trajectories to biologics for severe eosinophilic asthma and achievement of clinic...
New Trajectories in Lung Cancer - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Andrea Bianco discusses the novelties in treatement of lung cancer at the 13th International Workshop On Lung Health.Video: https://medicald...
Vaccinating respiratory patients: a new landscape - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Francesco Blasi explains his thoughts on vaccinating respiratory patients at the 13th International Workshop On Lung Health.Video: https://m...
Program Director's Choice from SABCS2025 - Part 3: Adding Tucatinib to First-line Maintenance Therapy Delayed Disease Progression in HER2-positive Metastatic Breast Cancer in HER2CLIMB-05 Trial
21 Jan 2026
Contributed by Lukas
Kate Lathrop, MD discuss one of the high impact, clinically relevant, clinical trial, the HER2CLIMB-05 trail that were presented at the San Antonio Br...
Program Director's Choice from SABCS2025 - Part 2: Sacituzumab Govitecan for Endocrine Therapy-refractory Advanced Breast Cancers
21 Jan 2026
Contributed by Lukas
Kate Lathrop, MD discuss one of the high impact, clinically relevant, clinical trial, the ASCENT-07 trial that were presented at the San Antonio Breas...
Program Director's Choice from SABCS2025 - Part 1 : Giredestrant Improves Disease-free Survival in Patients With Early-stage Breast Cancer in Phase III lidERA Trial
21 Jan 2026
Contributed by Lukas
Kate Lathrop, MD discuss one of the high impact, clinically relevant, clinical trial, the lidERA trial that were presented at the San Antonio Breast C...
Highligths of SABCS 2025
13 Jan 2026
Contributed by Lukas
Prof. Virginia G. Kaklamani discuss some of the high impact, clinically relevant, clinical trials that were presented at the San Antonio Breast Cancer...
Available Research Guiding the Selection of Therapy for Patients with Chronic Lymphocytic Leukemia - report from ASH 2025
09 Jan 2026
Contributed by Lukas
Matthew S. Davids discusses the available research guiding the selection of therapy for patients with chronic lymphocytic leukemia at the American Soc...
Lymphoma and CLL highlights of the ASH 2025
09 Jan 2026
Contributed by Lukas
Catherine S. Diefenbach discusses the lymphoma and CLL highlights at the American Society of Hematology's 67th Annual Meeting.Video: https://medic...
Quadruplet Therapy in Multiple Myeloma - report from ASH 2025
07 Jan 2026
Contributed by Lukas
Rahul Banerjee discusses the quadruplet therapy in multiple myeloma at the American Society of Hematology's 67th Annual Meeting.Video: https://med...
Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL - report from ASH 2025
07 Jan 2026
Contributed by Lukas
Jennifer Woyach discusses the noncovalent BTK inhibitor pirtobrutinib achieved noninferiority to the covalent BTK inhibitor ibrutinib in terms of over...
Primary efficacy analysis of TKI and inotuzumab ozogamicin-based therapy for newly diagnosed Ph+ ALL - report from ASH 2025
07 Jan 2026
Contributed by Lukas
Anand A. Patel discusses the primary efficacy analysis of a Phase II study investigating tyrosine kinase inhibitor and inotuzumab ozogamicin-based the...
Validation of measurable residual disease as a surrogate endpoint in acute myeloid leukemia: A HARMONY Alliance study of European randomized trials - report from ASH 2025
07 Jan 2026
Contributed by Lukas
Jesse Tettero discusses the results from the HARMONY Alliance study at the American Society of Hematology's 67th Annual Meeting.Video:
Symptom-based progression-free survival as a clinically relevant and patient-centric endpoint in chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the ALPINE trial
07 Jan 2026
Contributed by Lukas
Jennifer R. Brown explains the results from the ALPINE trial at the American Society of Hematology's 67th Annual Meeting.Video: https://medicaldig...
Azacitidine–Venetoclax Combination Outperforms Standard Care in Acute Myeloid Leukemia Patients Eligible for Intensive Chemotherapy - report from ASH 2025
07 Jan 2026
Contributed by Lukas
Amir Fathi discusses the results from a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemother...
What's new in myeloma? - report from ASH 2025
07 Jan 2026
Contributed by Lukas
Enrique Ocio discusses what's new in multiple myeloma treatement at the American Society of Hematology's 67th Annual Meeting.Video: https://me...
Novelties in Acute Myeloid Leukemia at ASH2025
07 Jan 2026
Contributed by Lukas
Mark Levis discusses the novelties in acute myeloid leukemia at the American Society of Hematology's 67th Annual Meeting.Video: https://medicaldig...
State of the art treatment of Chronic Myeloid Leukemia - report from ASH 2025
18 Dec 2025
Contributed by Lukas
Michael J. Mauro discusses the state of the art treatment of chronic myeloid leukemia at the American Society of Hematology's 67th Annual Meeting....
Myelodysplastic Syndrome Highlights from ASH 2025
18 Dec 2025
Contributed by Lukas
Mikkael A. Sekeres discusses the state of the art treatment in myelodysplastic syndrome at the American Society of Hematology's 67th Annual Meetin...
COBRA trial and other novelties in multiple myeloma at ASH 2025
18 Dec 2025
Contributed by Lukas
Andrzej Jakubowiak discusses the COBRA trial and other novelties in multiple myeloma at the American Society of Hematology's 67th Annual Meeting.V...
Multiple Myeloma Highlights from ASH 2025
18 Dec 2025
Contributed by Lukas
Paul G Richardson discusses multiple myeloma highlights at the American Society of Hematology's 67th Annual Meeting.Video: https://medicaldigest.o...
Diagnosis and Management of Cold Agglutinin Disease - report from ASH 2025
18 Dec 2025
Contributed by Lukas
Sigbjorn Berentsen discusses the diagnosis and management of cold agglutinin disease at the American Society of Hematology's 67th Annual Meeting.V...
Breakthrough in the treatement of Multiple Myeloma - report from ASH 2025
18 Dec 2025
Contributed by Lukas
Xavier Leleu explains the breakthrough in the treatement of multiple myeloma at the American Society of Hematology's 67th Annual Meeting.Video: ht...
Novelties in Diffuse Large B-cell Lymphoma at ASH2025
18 Dec 2025
Contributed by Lukas
Joshua Brody discusses the novelties in diffuse large B-cell lymphoma at the American Society of Hematology's 67th Annual Meeting.Video: https://m...
First-of-Its-Kind Phase 3 Trial Shows Pirtobrutinib Is Noninferior to Ibrutinib in Treatment-Naïve CLL - report from ASH 2025
17 Dec 2025
Contributed by Lukas
Wojciech Jurczak discusses the results from the global, randomized BRUIN CLL-313 study presented at the American Society of Hematology's 67th Annu...
New findings support a chemo-free approach for treating Ph+ ALL - report from ASH 2025
17 Dec 2025
Contributed by Lukas
Sabina Chiaretti discusses the results of the phase 3 GIMEMA ALL2820 study at the American Society of Hematology's 67th Annual Meeting.Video: http...
Novel Agent Ianalumab Added to Standard Therapy Extends Time to Treatment Failure in Patients with Previously Treated Immune Thrombocytopenia - report from ASH 2025
17 Dec 2025
Contributed by Lukas
Hanny Al-Samkari discusses the results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltro...
Bispecific Combo May Offer “Functional Cure” in Multiple Myeloma - report from ASH 2025
17 Dec 2025
Contributed by Lukas
María-Victoria Mateos discusses the results of a phase 3 study of teclistamab plus daratumumab for relapsed refractory multiple myeloma presented at ...
Epcoritamab Combo Significantly Improves Efficacy in 2L R/R Follicular Lymphoma - report from ASH 2025
17 Dec 2025
Contributed by Lukas
Lorenzo Falchi discusses the results of phase 3 EPCORE FL-1 trial presented at the American Society of Hematology's 67th Annual Meeting.Video: htt...
Novelties in Follicular Lymphoma at ASH2025
17 Dec 2025
Contributed by Lukas
Joshua Brody discusses the novelties in follicular lymphoma at the American Society of Hematology's 67th Annual Meeting.Video: https://medicaldige...
Remote BP Monitoring and Drug Titration – Does it work? How do we do it? - report from AHA 2025
03 Dec 2025
Contributed by Lukas
Professor Beverly B. Green shares her insights on remote BP monitoring and drug titrationat after the AHA Scientific Sessions 2025.Video: https://medi...
Effectiveness of High-Dose vs. Standard-Dose Inactivated Influenza Vaccine in Individuals with and without Atherosclerotic Cardiovascular Disease: A Pooled FLUNITY-HD Trial Analysis
03 Dec 2025
Contributed by Lukas
Professor Manan Pareek shares his insights on the results from the FLUNITY-HD trial analysis at AHA Scientific Sessions 2025.Video: https://medicaldig...
Blood Pressure and Symptomatic Hypotension with Dapagliflozin vs. Placebo in Patients Hospitalized with Heart Failure - report from AHA 2025
03 Dec 2025
Contributed by Lukas
Professor Siddharth M. Patel shares his insights on the results from the DAPA ACT HF-TIMI 68 trial at AHA Scientific Sessions 2025.Video: https://medi...
DASH-Patterned Groceries Reduce Blood Pressure - report from AHA 2025
03 Dec 2025
Contributed by Lukas
Professor Stephen P. Juraschek discusses the results from the GoFresh randomized clinical trial presented at at AHA Scientific Sessions 2025.Video: ht...
TUXEDO-2: Ticagrelor vs. Prasugrel in Patients With Diabetes and Multivessel Disease After PCI - report from AHA 2025
03 Dec 2025
Contributed by Lukas
Professor Sripal Bangalore discusses the findings from the TUXEDO-2 trial presented at at AHA Scientific Sessions 2025.Video: https://medicaldigest.or...
Aldosterone and Mineralocorticoid Receptors: New Paradigms and Novel Therapies - report from AHA 2025
03 Dec 2025
Contributed by Lukas
Professor John M. Flack shares his insights on the new paradigms and novel therapies in aldosterone and mineralocorticoid receptors at AHA Scientific ...
Navigating AHA Scientific Statements: Advancing Evidence-Based Cardiovascular Care - report from AHA 2025
03 Dec 2025
Contributed by Lukas
Professor Bradley S. Marino shares his insights on the advancing evidence-based cardiovascular care at AHA Scientific Sessions 2025.Video: https://med...
A Randomized Clinical Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Acute Coronary Syndrome Patients: The TARGET-D Trial - report from AHA 2025
02 Dec 2025
Contributed by Lukas
Professor Heidi T. May explains heart attack risk halved in adults with heart disease taking tailored vitamin D doses at AHA Scientific Sessions 2025....
First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides - report from AHA 2025
02 Dec 2025
Contributed by Lukas
Professor Stephen Nicholls shares his insights on the first-in-human trial of CRISPR gene-editing therapy at AHA Scientific Sessions 2025.Video: https...
Once-weekly Tirzepatide versus Dulaglutide for Heart Failure Outcomes in Patients with Type 2 Diabetes, ASCVD, and History of Heart Failure - report from AHA 2025
02 Dec 2025
Contributed by Lukas
Professor Stephen Nicholls shares his insights on the pre-specified analysis of the SURPASS-CVOT Randomized Clinical Trial at AHA Scientific Sessions ...
Impact of Cardiovascular-Focused Messaging to Improve Influenza Vaccination on Cardiovascular-Kidney-Metabolic Care Patterns and Clinical Outcomes: Insights from the KP VACCINATE Megatrial
02 Dec 2025
Contributed by Lukas
Professor Ankeet Bhatt shares his insights from the KP VACCINATE Megatrial presented at at AHA Scientific Sessions 2025.Videó: https://medicaldigest....
Resistance Exercise Therapy After COVID-19 Infection: a Randomized, Controlled Trial - report from AHA 2025
02 Dec 2025
Contributed by Lukas
Professor Stuart Gray shares his insights on the resistance exercise therapy after COVID-19 infection at AHA Scientific Sessions 2025.Video: https://m...
Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation - report from AHA 2025
02 Dec 2025
Contributed by Lukas
Professor Amrish Deshmukh shares his insights on metformin as an adjunctive therapy to catheter ablation of atrial fibrillation at AHA Scientific Sess...
Highlights of AHA / ACC Blood Pressure Management Guideline
02 Dec 2025
Contributed by Lukas
Professor Daniel Jones shares his insights on the AHA / ACC Blood Pressure Management Guideline at AHA Scientific Sessions 2025.Video: https://medical...
POLY-HF: Daily Polypill Boosts Heart Function, QOL, and Cuts Hospitalizations in Underserved Patients With HFrEF - report from AHA 2025
01 Dec 2025
Contributed by Lukas
Professor Ambarish Pandey presented the data of POLY-HF trial at AHA Scientific Sessions 2025.Video: https://medicaldigest.org/scientific-contents/int...
SOTA-P-CARDIA Trial: A Randomized Trial of Sotagliflozin in HFpEF patients without diabetes - report from AHA 2025
01 Dec 2025
Contributed by Lukas
Professor Juan J. Badimon discusses the SOTA-P-CARDIA Trial, a randomized trial of sotagliflozin in HFpEF patients without diabetes, presented at AHA ...
The Clinicians view on the 2025 Guideline for Acute Coronary Syndromes - report from AHA 2025
01 Dec 2025
Contributed by Lukas
Professor Matthew Tomey discusses the clinicians view on the2025 Guideline for Acute Coronary Syndromes at AHA Scientific Sessions 2025.Video: https:/...